{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:54:46Z","timestamp":1793656486350,"version":"4.5.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:00:00Z","timestamp":1683072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:00:00Z","timestamp":1683072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s12325-023-02482-5","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T09:02:16Z","timestamp":1683104536000},"page":"2869-2885","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Patient Management and Clinical Outcomes Associated with a Recorded Diagnosis of Stage 3 Chronic Kidney Disease: The REVEAL-CKD Study"],"prefix":"10.1007","volume":"40","clinical-trial-number":[{"clinical-trial-number":"nct04847531","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Navdeep","family":"Tangri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J.","family":"Peach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Franz\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela R.","family":"Kushner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,3]]},"reference":[{"issue":"11","key":"2482_CR1","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1093\/ndt\/gfz174","volume":"34","author":"KJ Jager","year":"2019","unstructured":"Jager KJ, Kovesdy C, Langham R, et al. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Nephrol Dial Transplant. 2019;34(11):1803\u20135.","journal-title":"Nephrol Dial Transplant"},{"key":"2482_CR2","unstructured":"United States Renal Data System. 2022 USRDS Annual Data Report: epidemiology of kidney disease in the United States. In: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 2022."},{"issue":"9889","key":"2482_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","volume":"382","author":"RT Gansevoort","year":"2013","unstructured":"Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339\u201352.","journal-title":"Lancet"},{"issue":"9888","key":"2482_CR4","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","volume":"382","author":"V Jha","year":"2013","unstructured":"Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260\u201372.","journal-title":"Lancet"},{"key":"2482_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1\u2013150.","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"2482_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.kint.2020.10.012","volume":"99","author":"MG Shlipak","year":"2021","unstructured":"Shlipak MG, Tummalapalli SL, Boulware LE, et al. The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 2021;99(1):34\u201347.","journal-title":"Kidney Int"},{"issue":"3s","key":"2482_CR7","first-page":"S1","volume":"99","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney\u00a0disease. Kidney Int. 2021;99(3s):S1\u201387.","journal-title":"Kidney Int"},{"key":"2482_CR8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/kisup.2013.27","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group","year":"2013","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group. KDIGO clinical practice guideline for lipid management in chronic kidney\u00a0disease. Kidney Int Suppl. 2013;3:259\u2013305.","journal-title":"Kidney Int Suppl"},{"issue":"5","key":"2482_CR9","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2022.06.008","volume":"102","author":"P Rossing","year":"2022","unstructured":"Rossing P, Caramori ML, Chan JCN, et al. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2022;102(5):S1\u2013127.","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"2482_CR10","first-page":"S175","volume":"45","author":"B Draznin","year":"2022","unstructured":"Draznin B, Aroda VR, Bakris G, et al. 11. Chronic kidney disease and risk management: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S175\u201384.","journal-title":"Diabetes Care"},{"issue":"9","key":"2482_CR11","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/eurjpc\/zwab034","volume":"29","author":"R Fontes-Carvalho","year":"2021","unstructured":"Fontes-Carvalho R, Santos-Ferreira D, Raz I, et al. Protective effects of SGLT-2 inhibitors across the cardiorenal continuum: two faces of the same coin. Eur J Prev Cardiol. 2021;29(9):1352\u201360.","journal-title":"Eur J Prev Cardiol"},{"issue":"17","key":"2482_CR12","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1161\/CIR.0000000000000920","volume":"142","author":"J Rangaswami","year":"2020","unstructured":"Rangaswami J, Bhalla V, Boer IHD, et al. Cardiorenal protection with the newer antidiabetic agents in patients with diabetes and chronic kidney disease: a scientific statement from the American Heart Association. Circulation. 2020;142(17):e265\u201386.","journal-title":"Circulation"},{"key":"2482_CR13","doi-asserted-by":"crossref","unstructured":"Tangri N, Moriyama T, Schneider MP, et al. REVEAL-CKD: management and monitoring of patients with stage 3 CKD in France, Germany, Italy, Japan and the USA [poster]. Presented at the American Society of Nephrology (ASN) Kidney Week 2022, November 3\u20136 2022, Orlando, Florida, USA.","DOI":"10.1681\/ASN.20223311S1302c"},{"key":"2482_CR14","doi-asserted-by":"crossref","unstructured":"De Nicola L, Peach E, Barone S, et al. MO509: REVEAL-CKD: prevalence of undiagnosed stage 3 chronic kidney disease in Italy [PowerPoint presentation]. Presented at the 59th European Renal Association Congress, May 19\u201322, 2022, Paris, France.","DOI":"10.1093\/ndt\/gfac071.040"},{"key":"2482_CR15","unstructured":"Chronic kidney disease often undiagnosed in Medicare beneficiaries. 2020. Accessed September 22, 2022, at https:\/\/www.cms.gov\/files\/document\/ckd-data-highlight102020-2.pdf."},{"key":"2482_CR16","unstructured":"Bakris G, Coresh J, Vassalotti JA, et al. Prevalence and factors associated with undiagnosed chronic kidney disease in diabetes mellitus. In: National Kidney Foundation 2019 Spring Clinical Meetings. Boston, MA, USA; 2019."},{"issue":"11","key":"2482_CR17","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.amjmed.2007.05.012","volume":"120","author":"TP Ryan","year":"2007","unstructured":"Ryan TP, Sloand JA, Winters PC, et al. Chronic kidney disease prevalence and rate of diagnosis. Am J Med. 2007;120(11):981\u20136.","journal-title":"Am J Med"},{"key":"2482_CR18","doi-asserted-by":"crossref","unstructured":"Sultan AA, Barone S, Kumar S, et al. 998-P: REVEAL-CKD: prevalence of and patient characteristics associated with undiagnosed stage 3 chronic kidney disease [poster]. Presented at the American Diabetes Association 81st Scientific Sessions, June 25\u201329, 2021 (virtual).","DOI":"10.2337\/db21-998-P"},{"issue":"2","key":"2482_CR19","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/j.ekir.2022.01.231","volume":"7","author":"M Schneider","year":"2022","unstructured":"Schneider M, Peach E, Barone S, et al. POS-213 REVEAL-CKD: prevalence of undiagnosed early chronic kidney disease in Germany. Kidney Int Rep. 2022;7(2):S93.","journal-title":"Kidney Int Rep"},{"issue":"9","key":"2482_CR20","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.2337\/dc20-2715","volume":"44","author":"N Stempniewicz","year":"2021","unstructured":"Stempniewicz N, Vassalotti JA, Cuddeback JK, et al. Chronic kidney disease testing among primary care patients with type 2 diabetes across 24 US Health Care Organizations. Diabetes Care. 2021;44(9):2000\u20139.","journal-title":"Diabetes Care"},{"issue":"9","key":"2482_CR21","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.2337\/dc21-0723","volume":"44","author":"D Alfego","year":"2021","unstructured":"Alfego D, Ennis J, Gillespie B, et al. Chronic kidney disease testing among at-risk adults in the US remains low: real-world evidence from a national laboratory database. Diabetes Care. 2021;44(9):2025\u201332.","journal-title":"Diabetes Care"},{"issue":"4","key":"2482_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1755-6686.2012.00323.x","volume":"38","author":"RC Greer","year":"2012","unstructured":"Greer RC, Crews DC, Boulware LE. Challenges perceived by primary care providers to educating patients about chronic kidney disease. J Ren Care. 2012;38(4):174\u201381.","journal-title":"J Ren Care"},{"issue":"1","key":"2482_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1515\/dx-2013-0029","volume":"1","author":"ES Holmboe","year":"2014","unstructured":"Holmboe ES, Durning SJ. Assessing clinical reasoning: moving from in vitro to in vivo. Diagnosis. 2014;1(1):111\u20137.","journal-title":"Diagnosis"},{"issue":"1","key":"2482_CR24","first-page":"112","volume":"30","author":"TE Paterick","year":"2017","unstructured":"Paterick TE, Patel N, Tajik AJ, et al. Improving health outcomes through patient education and partnerships with patients. Proc (Bayl Univ Med Cent). 2017;30(1):112\u20133.","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"10","key":"2482_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031625","volume":"9","author":"N Evangelidis","year":"2019","unstructured":"Evangelidis N, Craig J, Bauman A, et al. Lifestyle behaviour change for preventing the progression of chronic kidney disease: a systematic review. BMJ Open. 2019;9(10): e031625.","journal-title":"BMJ Open"},{"issue":"2","key":"2482_CR26","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1467-9566.2008.01152.x","volume":"31","author":"A Jutel","year":"2009","unstructured":"Jutel A. Sociology of diagnosis: a preliminary review. Sociol Health Illn. 2009;31(2):278\u201399.","journal-title":"Sociol Health Illn"},{"issue":"5 Pt 2","key":"2482_CR27","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1111\/j.1475-6773.2005.00444.x","volume":"40","author":"KJ O'Malley","year":"2005","unstructured":"O\u2019Malley KJ, Cook KF, Price MD, et al. Measuring diagnoses: ICD code accuracy. Health Serv Res. 2005;40(5 Pt 2):1620\u201339.","journal-title":"Health Serv Res"},{"issue":"4","key":"2482_CR28","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1093\/ckj\/sfab235","volume":"15","author":"P Kushner","year":"2021","unstructured":"Kushner P, Peach E, Wittbrodt E, et al. Investigating the global prevalence and consequences of undiagnosed stage 3 chronic kidney disease: methods and rationale for the REVEAL-CKD study. Clin Kidney J. 2021;15(4):738\u201346.","journal-title":"Clin Kidney J"},{"key":"2482_CR29","unstructured":"TriNetX Real World Data. 2021. Accessed September 22, 2022, at https:\/\/trinetx.com\/real-world-data\/linked\/."},{"issue":"9","key":"2482_CR30","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"2","key":"2482_CR31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1053\/j.ajkd.2021.08.003","volume":"79","author":"C Delgado","year":"2022","unstructured":"Delgado C, Baweja M, Crews DC, et al. A unifying approach for GFR estimation: recommendations of the NKF-ASN Task Force on reassessing the inclusion of race in diagnosing kidney disease. Am J Kidney Dis. 2022;79(2):268-88.e1.","journal-title":"Am J Kidney Dis"},{"key":"2482_CR32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1201\/9780203738535-7","volume-title":"Statistical models in S","author":"TJ Hastie","year":"2017","unstructured":"Hastie TJ. Generalized additive models. In: Statistical models in S. London: Routledge; 2017. p. 249\u2013307."},{"issue":"15","key":"2482_CR33","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jama.2011.451","volume":"305","author":"N Tangri","year":"2011","unstructured":"Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305(15):1553\u20139.","journal-title":"JAMA"},{"key":"2482_CR34","doi-asserted-by":"crossref","unstructured":"Harindhanavudhi T, Freese RL, Caramori L. 396-P: delayed chronic kidney disease (CKD) diagnosis in type 2 diabetes (T2D) [poster]. Presented at the American Diabetes Association 81st Scientific Sessions, June 25\u201329, 2021 (virtual).","DOI":"10.2337\/db21-396-P"},{"issue":"2","key":"2482_CR35","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.1016\/j.ekir.2022.01.316","volume":"7","author":"V Kim","year":"2022","unstructured":"Kim V, Gusmanov A, Sakko Y, et al. POS-296 late diagnosis of CKD and associated survival after initationt of renal replacement therapy in Kazakhstan: analysis of nationwide electronic healthcare registry 2014\u20132020. Kidney Int Rep. 2022;7(2):S132\u20133.","journal-title":"Kidney Int Rep"},{"issue":"12","key":"2482_CR36","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1093\/oxfordjournals.ndt.a027207","volume":"11","author":"R Sesso","year":"1996","unstructured":"Sesso R, Belasco AG. Late diagnosis of chronic renal failure and mortality on maintenance dialysis. Nephrol Dial Transplant. 1996;11(12):2417\u201320.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"2482_CR37","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1053\/j.ajkd.2015.10.011","volume":"67","author":"X Xie","year":"2016","unstructured":"Xie X, Liu Y, Perkovic V, et al. Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian network meta-analysis of randomized clinical trials. Am J Kidney Dis. 2016;67(5):728\u201341.","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"2482_CR38","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1001\/archinternmed.2011.2230","volume":"172","author":"SG Coca","year":"2012","unstructured":"Coca SG, Ismail-Beigi F, Haq N, et al. Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes. Arch Intern Med. 2012;172(10):761\u20139.","journal-title":"Arch Intern Med"},{"issue":"1","key":"2482_CR39","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s12325-021-01994-2","volume":"39","author":"CW Mende","year":"2022","unstructured":"Mende CW. Chronic kidney disease and SGLT2 inhibitors: a review of the evolving treatment landscape. Adv Ther. 2022;39(1):148\u201364.","journal-title":"Adv Ther"},{"key":"2482_CR40","unstructured":"US FDA approves INVOKANA\u00ae (canagliflozin) to treat diabetic kidney disease (DKD) and reduce the risk of hospitalization for heart failure in patients with type 2 diabetes (T2D) and DKD. 2019. Accessed January 12, 2023, at https:\/\/www.jnj.com\/u-s-fda-approves-invokana-canagliflozin-to-treat-diabetic-kidney-disease-dkd-and-reduce-the-risk-of-hospitalization-for-heart-failure-in-patients-with-type-2-diabetes-t2d-and-dkd."},{"issue":"2","key":"2482_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-052246","volume":"12","author":"L Zhang","year":"2022","unstructured":"Zhang L, Hauske S, Ono Y, et al. Analysis of eGFR index category and annual eGFR slope association with adverse clinical outcomes using real-world Japanese data: a retrospective database study. BMJ Open. 2022;12(2): e052246.","journal-title":"BMJ Open"},{"issue":"1","key":"2482_CR42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1053\/j.ajkd.2019.06.009","volume":"75","author":"AS Levey","year":"2020","unstructured":"Levey AS, Gansevoort RT, Coresh J, et al. Change in albuminuria and GFR as end points for clinical trials in early stages of CKD: a scientific workshop sponsored by the National Kidney Foundation in collaboration with the US Food and Drug Administration and European Medicines Agency. Am J Kidney Dis. 2020;75(1):84\u2013104.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"2482_CR43","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.kint.2019.02.022","volume":"95","author":"AA House","year":"2019","unstructured":"House AA, Wanner C, Sarnak MJ, et al. Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int. 2019;95(6):1304\u201317.","journal-title":"Kidney Int"},{"issue":"2","key":"2482_CR44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.5414\/CN108831","volume":"86","author":"J Wright Nunes","year":"2016","unstructured":"Wright Nunes J, Roney M, Kerr E, et al. A diagnosis of chronic kidney disease: despite fears patients want to know early. Clin Nephrol. 2016;86(2):78\u201386.","journal-title":"Clin Nephrol"},{"issue":"1","key":"2482_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000445450","volume":"134","author":"RJ Glassock","year":"2016","unstructured":"Glassock RJ, Rule AD. Aging and the kidneys: anatomy, physiology and consequences for defining chronic kidney disease. Nephron. 2016;134(1):25\u20139.","journal-title":"Nephron"},{"issue":"1","key":"2482_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000339327","volume":"36","author":"SJ Rosansky","year":"2012","unstructured":"Rosansky SJ. Renal function trajectory is more important than chronic kidney disease stage for managing patients with chronic kidney disease. Am J Nephrol. 2012;36(1):1\u201310.","journal-title":"Am J Nephrol"},{"issue":"10","key":"2482_CR47","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/qjmed\/hcv020","volume":"108","author":"SS Kao","year":"2015","unstructured":"Kao SS, Kim SW, Horwood CM, et al. Variability in inpatient serum creatinine: its impact upon short- and long-term mortality. QJM. 2015;108(10):781\u20137.","journal-title":"QJM"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02482-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-023-02482-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02482-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T14:26:43Z","timestamp":1729348003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-023-02482-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,3]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["2482"],"URL":"https:\/\/doi.org\/10.1007\/s12325-023-02482-5","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,3]]},"assertion":[{"value":"30 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}